Influenza virus hemagglutinin stalk-based antibodies and vaccinesEnhancement of Zika virus pathogenesis by preexisting antiflavivirus immunityDefining the antibody cross-reactome directed against the influenza virus surface glycoproteins.Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responsesInduction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humansNeutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodiesOne-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challengeAssessment of influenza virus hemagglutinin stalk-based immunity in ferrets.Divergent H7 immunogens offer protection from H7N9 virus challenge.Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.Advances in the development of influenza virus vaccines.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in MiceImmune history profoundly affects broadly protective B cell responses to influenza.Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.Novel universal influenza virus vaccine approachesTrichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccinesGlobular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistanceHemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice.1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humansB cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationEvaluation of the influenza A replicon for transient expression of recombinant proteins in mammalian cells.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Insect cells for antibody production: evaluation of an efficient alternative.An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates.Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses.Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.Animal models for influenza viruses: implications for universal vaccine development
P50
Q27001190-FB8A97A9-1136-408E-9E07-3E280C6F0A21Q29196526-4691AA0A-A7F4-42AB-A97B-BB8CCA5E168CQ30151352-1B8B1B72-9CA7-4102-A6CC-EFA84AD95BA0Q30151873-8BAE202B-A786-483B-A30F-F2CE1D3337D6Q30205195-14BC26D5-6970-4EF1-A28D-627AA5323E98Q30207889-0A45C71B-C787-4159-A942-D0F4AFAE47E6Q30352862-D6D812E6-5D2B-464F-A8EB-B973F62712E1Q30355516-81FDFBD4-4DFF-4A9B-BA14-CC9CFD95BC33Q30355863-C134B685-8C61-4258-BBA9-8AAD4BEFBEBBQ30356429-FCAE4B2B-9E03-4F9F-AF02-49227E85FD36Q30357665-EC17ED03-C717-47DD-9C80-BC27919F1DF1Q30358196-62D24BEC-DA7C-4003-A983-2B5F3E915CFEQ30364514-FEAA4478-D1E8-44D9-8AEA-390DD74B2FBBQ30366045-1C0A70D7-A6FC-493B-B72E-46E66E4EBB76Q30370147-7B61D677-5EBF-41B4-81FA-E7D4345FAF73Q30371836-D49AC333-13D8-40E2-8751-8BC759C8999AQ30372164-0F0AB4AC-2358-4A1B-BC50-271128E70BD3Q30372274-42A24C44-5FE5-4326-B7CC-699013B48540Q30380785-F36C0FE3-4A39-4326-8448-27346830B1D2Q30382131-0F8B4714-F257-4A18-A8F3-C77B5CF3EB68Q30382576-5214B8DF-C224-4779-B8AD-6A31750C3258Q30383973-55672B63-9688-4290-BFD8-C4E43DD89D25Q30385071-157659F5-59A0-47B8-BEB8-D7EB5B8A6FAEQ30387030-435D6A2C-89DE-4348-B81A-D28F4FB278A7Q30387031-3F24867B-D194-4EA7-8CDC-E34F29FC9F61Q30400179-CC5EB4F3-0081-4A20-958A-45B1A15E2280Q30412616-55077EC8-0DE8-4E79-A30F-0BCB01A4C198Q30413246-8B0C76FC-7769-4AED-AD52-F63C96B079F4Q30419085-D62755C4-4AD3-41B0-810E-C8ADCEC79497Q30422641-D3F6B663-1A09-47AE-8383-78BC3EF492A7Q30429248-643DDD71-D3B9-4636-A6BF-7719D0A30222Q33719206-50787615-B38A-46AD-A14C-5FBA6D9E9F8EQ33820732-266B9A7F-6A36-480E-8284-6AA8F87AB43AQ33866581-8DD6E25C-817E-4CA7-B5EC-6FBC6ACD2139Q34057737-47A6865E-16E6-4417-98A7-97B410B998C2Q34395834-3054C001-93A3-43C7-8C7C-B5C23D50E425Q34511080-312A9093-5C55-4AD9-AD5D-7A192D8C0FAEQ34555441-337FC402-6980-496B-B4C6-91E53EFB8C0FQ34594065-CD24D6D2-A5D1-4914-8797-F1A57829F049Q34809686-4736572E-F21B-4FE3-B854-8BBE1CD4928A
P50
description
Mikrobiologe
@de
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Florian Krammer
@ast
Florian Krammer
@de
Florian Krammer
@en
Florian Krammer
@es
Florian Krammer
@nl
Florian Krammer
@sl
type
label
Florian Krammer
@ast
Florian Krammer
@de
Florian Krammer
@en
Florian Krammer
@es
Florian Krammer
@nl
Florian Krammer
@sl
prefLabel
Florian Krammer
@ast
Florian Krammer
@de
Florian Krammer
@en
Florian Krammer
@es
Florian Krammer
@nl
Florian Krammer
@sl
P106
P1153
35362059600
P2002
florian_krammer
P21
P2798
P31
P496
0000-0003-4121-776X